
Carol Tadrous, MD
Elementy, w których Carol Tadrous, MD uczestniczy
niedziela 22 czerwiec, 2025
Learning ObjectivesAt the end of this session, participants will be able to:Assess uveitis guidelines to determine when referral to a uveitis specialist or rheumatologist for immunomodulatory treatment is necessary to prevent complications.Describe a new cl...
Learning ObjectivesAt the end of this session, participants will be able to:Apply uveitis guidelines to the diagnosis and management of scleritis and retinal vasculitis. Assess the impact of age on ...
Elementy, w których Carol Tadrous, MD attends
sobota 17 czerwiec, 2023
Learning Objectives: At the end of this session, participants will be able to: Enhance surgical strategies for routine cataractsDevelop an approach to complex cataract surgery: techniques, strategies, and instrumentationCanMEDS Roles: Medical expert, scholarX
Learning ObjectivesAt the end of this session, participants will be able to:Identify common reasons for discrepancy between structure and function evaluations of glaucoma patientsDescribe the difference between glaucomatous and non-glaucomatous abnormalities on glaucoma diagnostic testing
niedziela 18 czerwiec, 2023
Authors: Carol Tadrous , Steven Schendel, Kaivon Vaezi, Kulbir S. Gill, Mahadev Bhalla, Derek Chan, Claudio Perez. University of British Columbia. Author Disclosures: C. Tadrous: None. S. Schendel: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Abbvie, Alcon, Glaukos, Labtician, Thea, Bausch and Lomb. Any direct financial payments...